Drugs / Vizol S LIPID BALANCE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06323395 | Jun → Dec 2022 | dry eye syndrome | Jadran Galenski laboratorij d.d. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Vizol S LIPID BALANCE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06323395 ↗ |
| Route | Topical | “topical administration of 1 drop of Vizol S LIPID BALANCE in each eye 4 times a day for 30 days” NCT06323395 ↗ |